Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.68% | -105.50% | 2,535.43% | -13.73% | -5.95% |
| Total Depreciation and Amortization | -36.41% | 19.76% | 12.40% | 65.86% | -44.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,125.01% | -88.25% | 14,015.86% | 119.97% | -99.99% |
| Change in Net Operating Assets | 417.46% | -81.23% | 43.75% | -236.64% | 874.47% |
| Cash from Operations | -133.82% | -105.36% | 1,934.45% | -173.89% | 40.73% |
| Capital Expenditure | -359.95% | 41.58% | -7.32% | -441.58% | -353.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -207.83% | -- | -- |
| Other Investing Activities | 58.34% | 43.20% | -409.83% | 197.49% | 102.85% |
| Cash from Investing | 56.56% | 44.04% | -406.08% | 209.03% | 102.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.45% | -22.31% | -2.12% | 5.45% | -9.71% |
| Issuance of Common Stock | 775.66% | -92.99% | 664.12% | 4,276.54% | -98.41% |
| Repurchase of Common Stock | -- | 77.51% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 95.76% |
| Cash from Financing | 113.52% | 73.97% | -42,119.35% | 83.04% | 98.36% |
| Foreign Exchange rate Adjustments | -91.14% | 165.29% | -6,087.27% | -179.57% | 279.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.27% | -120.24% | 13,816.47% | 1,246.19% | 99.94% |